Cydan nabs $34 mln
Cambridge, Massachusetts-based Cydan, an orphan drug accelerator, has raised $34 million in funding. The investors were Longitude Capital, New Enterprise Associates, Pfizer Venture Investments, Alexandria Venture Investments and Lundbeckfond Ventures.
17 October 2017•1 min read
